Thu, October 29, 2020

Alethia Young Reiterated (AMGN) at Buy with Decreased Target to $278 on, Oct 29th, 2020

Alethia Young of Cantor Fitzgerald, Reiterated "Amgen Inc." (AMGN) at Buy with Decreased Target from $279 to $278 on, Oct 29th, 2020.

Alethia has made no other calls on AMGN in the last 4 months.



There are 10 other peers that have a rating on AMGN. Out of the 10 peers that are also analyzing AMGN, 5 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Initiated at Hold and Held Target at $232 on, Wednesday, October 28th, 2020
  • Robyn Karnauskas of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $251 on, Monday, October 12th, 2020
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, October 9th, 2020
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $250 on, Wednesday, July 29th, 2020
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $232 on, Wednesday, July 29th, 2020


These are the ratings of the 5 analyists that currently disagree with Alethia


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $284 on, Tuesday, October 27th, 2020
  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $255 on, Monday, October 26th, 2020
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $280 on, Tuesday, October 6th, 2020
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $300 on, Wednesday, July 29th, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $270 on, Wednesday, July 29th, 2020